| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/1991 | EP0447703A1 Hetero polycyclic biocidal compounds, their synthesis and intermediates therefor,formulations containing them and their use in medicine |
| 09/25/1991 | EP0447484A1 Antibacterial quinolone compounds |
| 09/25/1991 | EP0447414A1 Use of minoxidil for wound healing. |
| 09/25/1991 | EP0434743A4 Methods for preparing captopril and its analogues |
| 09/25/1991 | EP0311616B1 Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases |
| 09/25/1991 | EP0305380B1 Novel topical metronidazole formulations |
| 09/25/1991 | EP0229823B1 Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives |
| 09/25/1991 | CN1054778A Fluoroelastomers based on vinylidene fluoride hexafluoropropene and tetrafluoroethylene |
| 09/25/1991 | CN1054774A Three methods for obtaining pectin from abandoned bananas |
| 09/25/1991 | CN1054773A Hemoregulatory peptides |
| 09/25/1991 | CN1054771A Process for preparation of 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives |
| 09/25/1991 | CN1054770A Alkoxymethylidene epipodophyllotoxin glucosides |
| 09/25/1991 | CN1054769A Ganglioside derivatives |
| 09/25/1991 | CN1054767A Process for preparing synthesis of 5-acyloxy and 5-alkoxy-2,2-dihydro-4,6,7-trimethyl-2-(rs)-benzofuranacetic |
| 09/25/1991 | CN1054766A Urea derivatives and salts thereof, pharmaceutical compositions containing same, and methods for producing same |
| 09/25/1991 | CN1054714A Simple cosmetic device |
| 09/25/1991 | CN1014062B Method of combating microorganisms using heterocyclic pentalenes |
| 09/25/1991 | CN1014060B Method for preparaing ortho-azonaphthalene compound |
| 09/25/1991 | CN1014058B Process for preparation of 2-pyrrolidone derivative |
| 09/25/1991 | CN1014024B Process for preparing pharmaceuticals-formulation |
| 09/25/1991 | CA2038908A1 Indole derivatives |
| 09/25/1991 | CA2038741A1 Antiviral deoxynojirimycin derivatives |
| 09/24/1991 | WO1991014689A1 Antimalarial analogs of artemisinin |
| 09/24/1991 | US5051534 Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis |
| 09/24/1991 | US5051524 Substituted propane-phosphinic acid compounds |
| 09/24/1991 | US5051516 Chemical intermediates for central nervous system active drug s |
| 09/24/1991 | US5051515 Viricides |
| 09/24/1991 | US5051510 Piperidine derivatives as antihistaminics |
| 09/24/1991 | US5051508 Antisecretory agents and enzyme inhibitors as antiulcer agents |
| 09/24/1991 | US5051505 Process for preparing piperazinyl quinolone derivatives |
| 09/24/1991 | US5051449 Treatment of cellulite with retinoids |
| 09/24/1991 | US5051448 Gamma-aminobutyric acid derivatives that can cross brain barriers for a neurotransmitter |
| 09/24/1991 | US5051446 Cardiovascular disorders |
| 09/24/1991 | US5051445 3-amino-propyloxyphenyl derivatives, their preparation and pharmaceutical compositions containing them |
| 09/24/1991 | US5051443 Wound healing agents for eyes a nonsteroid antiinflammatory agent |
| 09/24/1991 | US5051442 3-indolyl thioacetate derivatives and NMDA receptor antagonistic use thereof |
| 09/24/1991 | US5051441 Immunomodulators and cardiovascular disorders |
| 09/24/1991 | US5051440 Nitrogen-containing heterocyclic compounds with antifungal action, use and a composition thereof |
| 09/24/1991 | US5051439 Allylaminoethyltnazoles as fungicides and antimycotic agents |
| 09/24/1991 | US5051438 Treating leukotriene by mediated diseases; antiinflammatory agents |
| 09/24/1991 | US5051435 Pharmaceutical preparations |
| 09/24/1991 | US5051433 For treatment of cardiovascular disorders such as hypertension |
| 09/24/1991 | US5051432 Heterocyclic 1,4 dihydropyridine derivatives |
| 09/24/1991 | US5051431 For treatment of congestive heart failure |
| 09/24/1991 | US5051430 Analgesics and antiinflammatory agents |
| 09/24/1991 | US5051426 Method for effecting withdrawal from drug dependency |
| 09/24/1991 | US5051425 Therapeutic composition for combatting AIDS |
| 09/24/1991 | US5051424 Piperazine compounds which act as sedatives or antidepressants |
| 09/24/1991 | US5051423 Cardiovascular disorders such as arrhythmia |
| 09/24/1991 | US5051422 2-substituted-1(4)-aryl piperazines and the process for their preparation |
| 09/24/1991 | US5051421 Analgesics and antiinflammatory agents |
| 09/24/1991 | US5051419 Adding 5-amino-7-(2-aminomethylmorpholino)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-acid |
| 09/24/1991 | US5051418 Antibacterial 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids |
| 09/24/1991 | US5051417 Indolythiadiazines for treating heart failure |
| 09/24/1991 | US5051416 Acetoxymethyl ester of 2-carbamoyloxymethyl-6- 1-hydroxyethyl!-2-penem-3-carboxylic acid |
| 09/24/1991 | US5051415 Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions |
| 09/24/1991 | US5051412 Compounds which may be used as psychotherapeutics for treatment of depression, obesity and aggression |
| 09/24/1991 | US5051411 A method of achieving an immunosuppressive effect |
| 09/24/1991 | US5051410 Method and composition for enhancing the release of neurotransmitters |
| 09/24/1991 | US5051408 Antitumor agents and insulin |
| 09/24/1991 | US5051407 Viricides |
| 09/24/1991 | US5051363 Method for modifying the toxicity of DNA reactive cross-linking agents to cells |
| 09/24/1991 | US5051263 Controlled-release formulations |
| 09/24/1991 | US5051258 Diets of gamma-aminobutyric acid, passion flow extract, taurine and vitamin B6 |
| 09/24/1991 | US5051257 Antineoplastic solution and method for treating neoplasms |
| 09/24/1991 | US5051253 Use of polyacrylates to reduce proteolytic activity in the human intestinal tract |
| 09/24/1991 | US5051132 Cardiovascular disorders for heart failure |
| 09/24/1991 | CA2054777A1 Antimalarial analogs of artemisinin |
| 09/24/1991 | CA1289569C Diphosphonic acid derivatives, processes for the preparation thereofand pharmaceutical compositions containing them |
| 09/24/1991 | CA1289565C2 Dihydropyridine-3,5-dicarboxylic acid ester derivatives |
| 09/24/1991 | CA1289563C Antiarrhythmic imidazoliums, intermediates thereto and method of use |
| 09/24/1991 | CA1289557C Oxime-ethers of 2,6-dioxobicyclo-[3.3.0] octanones for treatment of heart and circulation diseases |
| 09/24/1991 | CA1289555C Cephem compounds |
| 09/24/1991 | CA1289420C Method of producing high aqueous volume multilamellar vesicles |
| 09/23/1991 | CA2038539A1 Method for treating emotional numbness |
| 09/23/1991 | CA2038509A1 Bu-4164e - a and b, prolyl endopeptidase inhibitors |
| 09/23/1991 | CA2012998A1 Compounds |
| 09/22/1991 | WO1991014427A1 Eicosapentaenoic acids and methods for their production |
| 09/22/1991 | CA2078664A1 Eicosapentaenioc acids and methods for their production |
| 09/22/1991 | CA2038748A1 8-sulfamylmethylene-2-amino tetralins |
| 09/22/1991 | CA2038517A1 Squalene synthetase inhibitors |
| 09/22/1991 | CA2038496A1 Xanthomegnin, a known compound, is an antiparasitic agent |
| 09/22/1991 | CA2038450A1 Squalene synthetase inhibitors |
| 09/21/1991 | WO1991014679A1 Heterocyclic n-substituted derivatives, their preparation and thepharmaceutical compositions containing them |
| 09/21/1991 | CA2038589A1 Substituted purines, processes for their preparation and their use as antiviral agents |
| 09/21/1991 | CA2012690A1 Direct delivery of anti-inflammatories to the proximal small bowel |
| 09/20/1991 | WO1991014683A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors |
| 09/20/1991 | WO1991014682A1 Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors |
| 09/20/1991 | WO1991014430A1 Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors |
| 09/20/1991 | WO1991014428A1 USE OF 5-TRANS PROSTAGLANDIN F2α AS AN OCULAR HYPOTENSIVE AGENT |
| 09/20/1991 | CA2332618A1 Liquid lavage/ventilation of the pulmonary system |
| 09/20/1991 | CA2095050A1 Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors |
| 09/20/1991 | CA2078669A1 Topically active ocular thiadiazole sulfonamide carbonic anhydrase |
| 09/20/1991 | CA2077995A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors |
| 09/20/1991 | CA2076023A1 Use of 5-trans prostaglandin f as an ocular hypotensive agent |
| 09/20/1991 | CA2038532A1 Antibiotic agents |
| 09/20/1991 | CA2038528A1 Lipopeptide derivatives |
| 09/20/1991 | CA2038527A1 Therapeutic agent for ischemic diseases |
| 09/20/1991 | CA2038428A1 Pyrazole derivatives which are angiotensin ii receptor antagonists; their methods of preparation and pharmaceutical compositions in which they are present |
| 09/20/1991 | CA2037561A1 Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromboxane a2 receptor antagonist and combination useful in preventing and/or treatingulcers and/or inflammation |